JP2011251959A5 - - Google Patents

Download PDF

Info

Publication number
JP2011251959A5
JP2011251959A5 JP2011100277A JP2011100277A JP2011251959A5 JP 2011251959 A5 JP2011251959 A5 JP 2011251959A5 JP 2011100277 A JP2011100277 A JP 2011100277A JP 2011100277 A JP2011100277 A JP 2011100277A JP 2011251959 A5 JP2011251959 A5 JP 2011251959A5
Authority
JP
Japan
Prior art keywords
excipients
particle size
preparation
particle
ambroxol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011100277A
Other languages
English (en)
Japanese (ja)
Other versions
JP6084355B2 (ja
JP2011251959A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2011100277A priority Critical patent/JP6084355B2/ja
Priority claimed from JP2011100277A external-priority patent/JP6084355B2/ja
Publication of JP2011251959A publication Critical patent/JP2011251959A/ja
Publication of JP2011251959A5 publication Critical patent/JP2011251959A5/ja
Application granted granted Critical
Publication of JP6084355B2 publication Critical patent/JP6084355B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011100277A 2010-05-06 2011-04-28 アンブロキソール含有製剤粒子 Active JP6084355B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2011100277A JP6084355B2 (ja) 2010-05-06 2011-04-28 アンブロキソール含有製剤粒子

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2010106158 2010-05-06
JP2010106158 2010-05-06
JP2011100277A JP6084355B2 (ja) 2010-05-06 2011-04-28 アンブロキソール含有製剤粒子

Publications (3)

Publication Number Publication Date
JP2011251959A JP2011251959A (ja) 2011-12-15
JP2011251959A5 true JP2011251959A5 (hr) 2014-05-08
JP6084355B2 JP6084355B2 (ja) 2017-02-22

Family

ID=45416214

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011100277A Active JP6084355B2 (ja) 2010-05-06 2011-04-28 アンブロキソール含有製剤粒子

Country Status (1)

Country Link
JP (1) JP6084355B2 (hr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5758552B2 (ja) * 2013-05-08 2015-08-05 全星薬品工業株式会社 機能性高分子皮膜で被覆された高含量薬物粒子およびそれを含む錠剤ならびにそれらの製造方法
KR102083621B1 (ko) * 2013-06-13 2020-03-02 한미약품 주식회사 암브록솔 및 레보드로프로피진을 포함하는 안정성이 개선된 경구용 액상 제제
CN104606170A (zh) * 2015-02-04 2015-05-13 上海华源安徽仁济制药有限公司 一种盐酸氨溴索胶囊及其制备方法
CN107569473B (zh) * 2017-09-28 2021-01-19 南京易亨制药有限公司 一种盐酸氨溴索缓释胶囊及其制备方法
CN111135152A (zh) * 2020-01-19 2020-05-12 安徽省先锋制药有限公司 一种盐酸氨溴索胶囊的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0774166B2 (ja) * 1987-02-06 1995-08-09 信越化学工業株式会社 徐放性被覆薬剤の製造方法
IT1252185B (it) * 1991-12-11 1995-06-05 Therapicon Srl Preparazioni farmaceutiche a liberazione programmata
JP3170069B2 (ja) * 1992-10-06 2001-05-28 日水製薬株式会社 徐放性顆粒剤
JPH09315969A (ja) * 1996-05-24 1997-12-09 Taiyo Yakuhin Kogyo Kk イブジラスト含有徐放性医薬品組成物及びその製造方法
JP3677156B2 (ja) * 1997-09-05 2005-07-27 武田薬品工業株式会社 医薬
JPH11209306A (ja) * 1998-01-20 1999-08-03 Nichiko Pharmaceutical Co Ltd 高薬物含有率徐放製剤の製法
JP4367722B2 (ja) * 1998-04-17 2009-11-18 大正製薬株式会社 マルチプルユニットタイプ徐放性錠剤
JP4974419B2 (ja) * 2001-06-12 2012-07-11 東和薬品株式会社 薬物含有徐放性顆粒およびそれを含む錠剤
JP4494712B2 (ja) * 2002-11-12 2010-06-30 大日本住友製薬株式会社 マルチプルユニット型徐放性製剤
JP2008201706A (ja) * 2007-02-20 2008-09-04 Kowa Pharmaceutical Co Ltd 小型徐放性錠剤

Similar Documents

Publication Publication Date Title
JP2014005302A5 (hr)
JP2015525757A5 (hr)
JP2012503668A5 (hr)
JP2013014622A5 (hr)
JP2013525444A5 (hr)
JP2014507482A5 (hr)
JP2011251959A5 (hr)
PH12015501756A1 (en) Tamper resistant pharmaceutical formulations
JP2009512663A5 (hr)
JP2013510216A5 (hr)
JP2016512248A5 (hr)
AU2012351112A8 (en) Composite filler particles and process for the preparation thereof
JP2014526447A5 (hr)
JP2012085643A5 (hr)
IL239325A0 (en) An oral dosage form that includes crush-resistant coated particles for immediate release of at least one active compound
WO2012051426A3 (en) Aggregate nanoparticulate medicament formulations, manufacture and use thereof
SG10201805657PA (en) Composite formulation for oral administration comprising ezetimibe and rosuvastatin
JP2012021008A5 (hr)
MX336777B (es) Peliculas y composiciones que comprenden las mismas.
WO2015003479A3 (zh) 一种适用于婴幼儿及儿童的口服固体颗粒及其制备方法
JP2012067297A5 (hr)
JP2012115255A5 (hr)
JP2011251985A5 (hr)
JP2014062109A5 (hr)
JP2012512815A5 (hr)